financetom
Business
financetom
/
Business
/
Looking At Snowflake's Recent Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Looking At Snowflake's Recent Unusual Options Activity
Aug 21, 2025 10:29 AM

Financial giants have made a conspicuous bullish move on Snowflake. Our analysis of options history for Snowflake revealed 38 unusual trades.

Delving into the details, we found 47% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $1,041,125, and 24 were calls, valued at $2,286,457.

Expected Price Movements

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $145.0 to $230.0 for Snowflake over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for Snowflake options trades today is 1003.52 with a total volume of 10,166.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Snowflake's big money trades within a strike price range of $145.0 to $230.0 over the last 30 days.

Snowflake Option Volume And Open Interest Over Last 30 Days

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
SNOW CALL TRADE BEARISH 08/29/25 $3.6 $3.45 $3.49 $220.00 $379.0K 1.1K 2.1K
SNOW CALL TRADE BEARISH 08/29/25 $3.5 $3.3 $3.34 $220.00 $350.7K 1.1K 1.0K
SNOW PUT SWEEP BULLISH 09/18/26 $30.15 $30.1 $30.1 $190.00 $273.9K 5 91
SNOW CALL SWEEP BEARISH 09/19/25 $12.15 $12.05 $12.07 $200.00 $186.1K 2.2K 616
SNOW PUT TRADE BEARISH 11/21/25 $3.05 $2.92 $3.0 $145.00 $180.0K 181 600

About Snowflake

Founded in 2012, Snowflake is a fully managed platform that consolidates data hosted on different public clouds for centralized analytics and governance. Snowflake's cloud-native architecture allows users to independently scale the compute and storage layers, providing customers with optimized performance at lower costs. The company's data lake and data warehouse products support a variety of use cases, including business analytics, data engineering, and artificial intelligence. Snowflake is widely used by Fortune 2000 companies in financial services, media, and retail sectors.

After a thorough review of the options trading surrounding Snowflake, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Current Position of Snowflake

Currently trading with a volume of 1,403,496, the SNOW's price is down by -0.17%, now at $194.46.

RSI readings suggest the stock is currently may be approaching oversold.

Anticipated earnings release is in 6 days.

Expert Opinions on Snowflake

In the last month, 2 experts released ratings on this stock with an average target price of $245.0.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

* Showing optimism, an analyst from B of A Securities upgrades its rating to Buy with a revised price target of $240.

* An analyst from UBS has decided to maintain their Buy rating on Snowflake, which currently sits at a price target of $250.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Snowflake, Benzinga Pro gives you real-time options trades alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: BP to Appoint 2 New Directors Amid Renewed Focus on Oil, Gas
Update: Market Chatter: BP to Appoint 2 New Directors Amid Renewed Focus on Oil, Gas
Mar 4, 2025
02:14 PM EST, 03/04/2025 (MT Newswires) -- (Updates with the company's response in the seventh paragraph and latest stock move at the end.) BP (BP) plans to appoint two new directors as part of its shift back to oil and gas, the Financial Times reported Tuesday, citing sources familiar with the matter. Chair Helge Lund reportedly wants the board to...
Apple appeals to overturn UK government's 'back door' order, FT reports
Apple appeals to overturn UK government's 'back door' order, FT reports
Mar 4, 2025
March 4 (Reuters) - Apple ( AAPL ) has appealed a British government order to create a back door in its most secure cloud storage systems, the Financial Times reported on Tuesday, citing people familiar with the matter. The iPhone maker removed its most advanced security encryption for cloud data, called Advanced Data Protection (ADP), in Britain last month, in...
What's Going On With Bank of America (BAC) Shares
What's Going On With Bank of America (BAC) Shares
Mar 4, 2025
Bank of America Corp ( BAC ) shares are trading lower by 5.7% to $42.95 Tuesday afternoon as fears surrounding U.S. tariffs on Mexico and Canada added to broader market uncertainty. What To Know: President Donald Trump's firm stance against further trade negotiations has heightened concerns about economic growth, a key factor affecting the bank's lending and investment operations. As...
GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report
GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report
Mar 4, 2025
The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and value of GSK Plc's ( GSK ) chronic obstructive pulmonary disease (COPD) treatments, Trelegy Ellipta and Breo Ellipta. Under the Inflation Reduction Act, CMS is negotiating prices for select Medicare Part D drugs. In the current cycle, Trelegy Ellipta and Breo Ellipta...
Copyright 2023-2025 - www.financetom.com All Rights Reserved